Widely Prescribed Anti-parasite Drug Targets Cancer-causing Protein, New York University Cancer Institute and Ronald O. Perelman Department of Dermatology Research
ScienceDaily (Aug. 7, 2008) — Researchers at the NYU Cancer Institute and the Ronald O. Perelman Department of Dermatology have identified mebendazole, a drug used globally to treat parasitic infections, as a novel investigational agent for the treatment of chemotherapy-resistant malignant melanoma.